Top Qs
Timeline
Chat
Perspective
Cureus
Open access general medical journal with post-publication peer review From Wikipedia, the free encyclopedia
Remove ads
Cureus: Journal of Medical Science is a web-based open access general medical journal that uses an accelerated pre-publication peer-review and an optional post-publication peer review. It is also the first academic journal which provides authors with step-by-step templates for them to use to write their papers.[1] The journal's founding editors-in-chief are John R. Adler (Stanford University) and Alexander Muacevic (University of Munich).[2]
Remove ads
History and publication process
The journal was originally started as PeerEMed in 2009, obtaining its current name in December 2012.[1] Under its system, after an article is published, anyone can review it, but the reviews of experts will be given a higher score.[3] As of December 2022, the journal became part of the Springer Nature group of journals.[4]
If certain criteria are met, Cureus does not charge publication fees.[5]
Remove ads
Abstracting and indexing
The journal has been abstracted and indexed in the Emerging Sources Citation Index. As of October 2024[update], the journal's indexation in the Web of Science indices is "on hold" and pending re-evaluation, with the concerns on "the quality of the content published in this journal" being cited as a reason for the suspension.[6]
Reception
Summarize
Perspective
Cureus's peer-review process involves asking experts to review a given article in a few days, resulting in its peer reviews taking much less time than most other journals.[3] Adler told Retraction Watch in 2015:
Yes, Cureus has an unusually fast review process, which is an important part of the journal’s philosophy. We believe that post publication [sic] peer review, a focus of our journal through commenting and our unique SIQ process, is potentially a more powerful way to discern truth.[7]
SIQ refers to Cureus's trademarked Scholarly Impact Quotient, a statistic calculated post-publication that takes peer opinions into account.[8] Nevertheless, the speed and the quality of the journal's peer review process, as well as the article-level SIQ metric used by Cureus, has attracted the criticism of librarians and scientists who worry that the SIQ could be gamed.[9][10][11]
In June 2022, Cureus was again criticized by Retraction Watch for republishing a previously retracted paper. The original paper,[12] published on 19 July 2021 in Frontiers in Medicine, had been retracted due to methodological issues and concerns regarding potential violations of medical ethics and human rights related to a COVID-19 proxalutamide trial in Brazil.[13]
Earlier, in April 2022, Cureus displayed a 'wall of shame' to "highlight authors who have committed egregious ethical violations as well as the institutions that enabled them".[14] The feature faced criticism for potentially placing undue emphasis on individuals, especially corresponding authors; it was removed from the site in May 2023. Also in April 2022, Cureus published notes of concern relating to nearly 50 papers published without the knowledge of the corresponding author or with disputed authorship. In January 2024, 56 papers were retracted.[15]
In November 2024, after having previously defended them, Cureus closed six of its "academic channels." These "channels" were essentially governed by an external entity that selectively appointed editors to manage the entire process from content submission to publication. Numerous sources have associated these channels with research paper mills.[16]
Remove ads
References
External links
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads